Chemed Corporation (NYSE:CHE) Receives $501.50 Average Price Target from Analysts

Posted by Brian Himes on May 19th, 2026

Shares of Chemed Corporation (NYSE:CHE – Get Free Report) have received a consensus rating of “Hold” from the six research firms that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $501.50.

CHE has been the topic of several recent analyst reports. Oppenheimer cut their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Royal Bank Of Canada upped their price objective on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd.

Check Out Our Latest Research Report on Chemed

Chemed Stock Up 1.7%

NYSE:CHE opened at $441.90 on Friday. Chemed has a 1-year low of $365.20 and a 1-year high of $583.96. The company has a 50-day moving average of $397.32 and a 200 day moving average of $425.14. The firm has a market cap of $5.86 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 1.63 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed (NYSE:CHE – Get Free Report) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the company posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, research analysts anticipate that Chemed will post 22.3 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date is Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Monetary Solutions Ltd acquired a new position in Chemed in the 4th quarter valued at $25,000. Los Angeles Capital Management LLC acquired a new stake in shares of Chemed during the 4th quarter worth about $26,000. Smartleaf Asset Management LLC increased its position in shares of Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new position in Chemed in the 4th quarter valued at about $27,000. Finally, First Horizon Corp acquired a new position in Chemed in the 3rd quarter valued at about $31,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.